Table 3.
Compound | Cell line | Cell cycle distribution (%) |
||
---|---|---|---|---|
G1 | S | G2 | ||
Control | LNCaP | 72.50 | 8.95 | 8.55 |
2 | LNCaP | 85.23 | 9.18 | 5.59 |
Control | PC3 | 47.29 | 21.15 | 31.56 |
2 | PC3 | 64.35 | 19.91 | 15.74 |
SAHA | PC3 | 72.28 | 14.33 | 13.39 |
Control | A549 | 79.27 | 9.81 | 10.93 |
2 | A549 | 82.63 | 2.03 | 15.34 |
SAHA | A549 | 88.58 | 2.00 | 9.41 |
Control | MCF-7 | 62.03 | 29.73 | 8.24 |
2 | MCF-7 | 75.76 | 12.94 | 11.30 |
SAHA | MCF-7 | 77.43 | 6.68 | 15.89 |
NOTE: GI50s of SAHA at 1.04 µmol/L for PC3 and the compound 2 at 1.54 µmol/L for PC3 and 1.3 µmol/L for LNCaP were used. A549 cells were treated with 10 µmol/L of compound 2 and SAHA. No obvious change at 1 µmol/L concentration was observed. MCF-7 cells were treated with 1 µmol/L of compound 2 and SAHA.